AsclepiX Investigative Site is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.
AsclepiX Investigative Site has participated in 2 clinical trials.
Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema (DME).
Sponsors: AsclepiX Therapeutics, Inc..
Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
AsclepiX Investigative Site has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
AsclepiX Investigative Site has 2 clinical trials on record. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema (DME).
AsclepiX Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.